The role of antigen presenting cells in multiple sclerosis - PubMed (original) (raw)

Review

The role of antigen presenting cells in multiple sclerosis

Emily M L Chastain et al. Biochim Biophys Acta. 2011 Feb.

Abstract

Multiple sclerosis (MS) is a debilitating T cell mediated autoimmune disease of the central nervous system (CNS). Animal models of MS, such as experimental autoimmune encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) have given light to cellular mechanisms involved in the initiation and progression of this organ-specific autoimmune disease. Within the CNS, antigen presenting cells (APC) such as microglia and astrocytes participate as first line defenders against infections or inflammation. However, during chronic inflammation they can participate in perpetuating the self-destructive environment by secretion of inflammatory factors and/or presentation of myelin epitopes to autoreactive T cells. Dendritic cells (DC) are also participants in the presentation of antigen to T cells, even within the CNS. While the APCs alone are not solely responsible for mediating the destruction to the myelin sheath, they are critical players in perpetuating the inflammatory milieu. This review will highlight relevant studies which have provided insight to the roles played by microglia, DCs and astrocytes in the context of CNS autoimmunity.

2010 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52:61–76. - PubMed
    1. Paterson PY, Swanborg RH. Demyelinating diseases of the central and peripheral nervous systems. In: Sampter M, Talmage DW, Frank MM, Austen KF, Claman HN, editors. Immunological Diseases. Vol. 4. Little, Brown and Co.; Boston: 1988. pp. 1877–1916.
    1. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–269. - PubMed
    1. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9:839–855. - PubMed
    1. Turley DM, Miller SD. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis. Results Probl Cell Differ. 2009 - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources